Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Jun 15;549(Pt 3):667-72.
doi: 10.1113/jphysiol.2003.043976. Epub 2003 May 9.

Inhibition of HERG K+ current and prolongation of the guinea-pig ventricular action potential by 4-aminopyridine

Affiliations

Inhibition of HERG K+ current and prolongation of the guinea-pig ventricular action potential by 4-aminopyridine

J M Ridley et al. J Physiol. .

Abstract

4-Aminopyridine (4-AP) has been used extensively to study transient outward K+ current (ITO,1) in cardiac cells and tissues. We report here inhibition by 4-AP of HERG (the human ether-à-go-go-related gene) K+ channels expressed in a mammalian cell line, at concentrations relevant to those used to study ITO,1. Under voltage clamp, whole cell HERG current (IHERG) tails following commands to +30 mV were blocked with an IC50 of 4.4 +/- 0.5 mM. Development of block was contingent upon HERG channel gating, with a preference for activated over inactivated channels. Treatment with 5 mM 4-AP inhibited peak IHERG during an applied action potential clamp waveform by ~59 %. It also significantly prolonged action potentials and inhibited resurgent IK tails from guinea-pig isolated ventricular myocytes, which lack an ITO,1. We conclude that by blocking the alpha-subunit of the IKr channel, millimolar concentrations of 4-AP can modulate ventricular repolarisation independently of any action on ITO,1.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Concentration and voltage-dependent inhibition of IHERG by 4-AP
A, upper traces show representative current traces illustrating the effect of different concentrations of 4-AP. Lower trace represents voltage protocol used. B, concentration response relation for IHERG tail blockade by 4-AP (n = 5–8 cells at each concentration). C, representative records in the absence (Ci) and presence (Cii) of 5 mm 4-AP. D, the mean (± s.e.m.) fractional block of IHERG by 5 mm 4-AP over a range of potentials (n = 8 cells). IHERG activation curves are shown in the absence (continuous line) and presence (dashed line) of 5 mm 4-AP.
Figure 2
Figure 2. Time dependence of IHERG block by 4-AP
A, traces from an ‘envelope of tails’ protocol, in the absence (Ai) and presence (Aii) of 5 mm 4-AP. Lower traces represent the voltage protocol used. B, the mean (± s.e.m.) fractional block of IHERG with varying pulse duration (n = 5 cells). The τ for development of inhibition was 32.3 ± 6.4 ms (n = 5).
Figure 3
Figure 3. Effect of strong depolarisation on the action of 4-AP
A, current records (upper traces) elicited by the voltage protocol shown (lower trace), applied from a holding potential of −80 mV. Arrows indicate traces obtained in control and 4-AP. B, bar charts (n = 5 cells) compare the mean level of blockade at 1000 ms into protocol (at +20 mV), at 4000 ms (at +80 mV) and at 9000 ms (after membrane potential was returned to +20 mV).
Figure 4
Figure 4. Effect of 4-AP under action potential conditions
A, representative records of IHERG, after P/4 leak subtraction, (upper traces) activated by ventricular action potential command (lower trace), in control and in the presence of 5 mm 4-AP. B, effect of 5 mm 4-AP on action potentials from guinea-pig ventricular myocytes. C, effect of 4-AP on resurgent IK tails from a guinea-pig ventricular myocyte (upper traces; lower trace shows a section of the voltage protocol. A mean inhibition of 71.1 ± 4.3 % was observed (n = 6).

Similar articles

Cited by

References

    1. Castle NA, Slawsky MT. Characterization of 4-aminopyridine block of the transient outward K+ current in adult rat ventricular myocytes. J Pharmacol Exp Ther. 1993;265:1450–1459. - PubMed
    1. Coraboeuf E, Coulombe A, Deroubaix E, Hatem S, Mercadier JJ. Transient outward potassium current and repolarization of cardiac cells. Bull Acad Natl Med. 1998;182:325–333. - PubMed
    1. del Balzo U, Rosen MR. T wave changes persisting after ventricular pacing in canine heart are altered by 4-aminopyridine but not by lidocaine. Implications with respect to phenomenon of cardiac ‘memory’. Circulation. 1992;85:1464–1472. - PubMed
    1. Elizalde A, Barajas H, Navarro-Polanco R, Sanchez-Chapula J. Frequency-dependent effects of 4-aminopyridine and almokalant on action-potential duration of adult and neonatal rabbit ventricular muscle. J Cardiovasc Pharmacol. 1999;33:352–359. - PubMed
    1. Faivre JF, Calmels TP, Rouanet S, Javre JL, Cheval B, Bril A. Characterisation of Kv4. 3 in HEK293 cells: comparison with the rat ventricular transient outward potassium current. Cardiovasc Res. 1999;41:188–199. - PubMed

MeSH terms

LinkOut - more resources